Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Medical Microbiology and Immunology
Published in: Medical Microbiology and Immunology 1/2011

01-02-2011 | Review

Hidden hazards of HCV transmission

Author: Robério Amorim de Almeida Pondé

Published in: Medical Microbiology and Immunology | Issue 1/2011

Login to get access

Abstract

Hepatitis C virus infection is a global health problem that has important epidemiological and clinical consequences. It has been well established that exposure to infected blood is the main risk factor for HCV transmission. However, in 20% of cases the agent transmission occurs by unknown route or in the presence of an unidentified source of infection. Understanding of the epidemiology of HCV is needed to help us define future control and preventive strategies. Herein, we discuss about diagnosis of HCV infection and hepatitis C surveillance in the context of its transmission.
Literature
1.
Kao JH, Chen DS (2000) Transmission of hepatitis C virus in Asia: past and present perspectives. J Gastroenterol Hepatol 15(Suppl):E91–E96CrossRefPubMed
2.
Hwang SJ, Lee SD, Lu RH (2001) Hepatitis C viral genotype influences the clinical outcome of patients with acute post-transfusion hepatitis C. J Med Virol 65:505–509CrossRefPubMed
3.
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O’Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461(7265):798–801CrossRefPubMed
4.
Tellinghuisen TL, Evans MJ, von Hahn T, You S, Rice CM (2007) Studying Hepatitis C virus: making the best of a bad virus. J Virol 81(17):8853–8867CrossRefPubMed
5.
Alter M (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44:6–9CrossRef
6.
Prati D (2006) Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 45:607–616CrossRefPubMed
7.
Schreiber G, Busch M, Kleinman S, Korelitz J (1996) The risk of transfusion-transmitted viral infections. N Eng J Med 26(334):1687–1690
8.
Roy KM, Goldberg D, Taylor A, Mills P (2003) Investigation the source of hepatitis C virus infection among individuals whose route of infection is undefined: a study of ten cases. Scan J Infect Dis 35:326–328CrossRef
9.
Blackard JT, Shata MT, Shire NJ, Sherman KE (2008) Acute hepatitis C virus infection: a chronic problem. Hepatology 47(1):321–331CrossRefPubMed
10.
Giachetti C, Linnen J, Kolk D, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick M, Mimms L, McDonough S (2002) Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 7(40):2408–2419CrossRef
11.
Kolk D, Dockter J, Linnen J, Ho-Sing-Loy M, Gillotte-Taylor K, McDonough S, Mimms L, Giachetti C (2002) Significant closure of the Human Immunodeficiency Virus Type 1 and Hepatitis C Virus preseroconversion detection windows with a transcription-mediated-amplification driven assay. J Clin Microbiol 5(40):1761–1766CrossRef
12.
Idrees M, Riazuddin S (2008) Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Inf Dis 8:69CrossRef
13.
Rè V, Gallego S, Farías A, Barbás G, Kremer L, Díaz M, Contigiani M (2008) Hepatitis C and HIV coinfection in central region of Argentina: prevalence, genotype characterization and risk factors. Enferm Infecc Microbiol Clin 26(7):423–425CrossRefPubMed
14.
Abou-Setta AM (2004) Transmission risk of hepatitis C virus via semen during assisted reproduction: how reals is it? Hum Reprod 12(19):2711–2717CrossRef
15.
Thompson S, Boughton C, Dore G (2003) Blood-borne viruses and their survival in the environment: is public concern about community needlestick exposures justified? Aust N Z J Public Health 27(6):602–607CrossRefPubMed
16.
Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, Prins M (2009) Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 23(12):F1–F7CrossRefPubMed
17.
Danta M, Brown D, Bhagani S, Pybus OG, Sabin CA, Nelson M, Fischer M, Johnson AM, Dusheiko GM (2007) Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 21(8):983–991CrossRefPubMed
18.
van de Laar TJ, van der Laar Bij AK, Prins M, Bruisten SM, Brinkman K, Ruys TA, van der Meer JT, de Vries HJ, Mulder JW, van Agtmael M, Jurriaans S, Wolthers KC, Coutinho RA (2007) Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 196(2):230–238CrossRefPubMed
19.
Indolfi G, Rest M (2009) Perinatal transmission of hepatitis C virus infection. J Med Virol 81(5):836–843CrossRefPubMed
20.
Steininger C, Kundi M, Jatzko G, Kiss H, Lischka A, Holzmann H (2003) Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis 187(3):345–351CrossRefPubMed
21.
Mok J, Pembrey L, Tovo P-A, Newell M-L (2004) When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal 90:156–160CrossRef
22.
Kumar RM, Shahul S (1998) Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. J Hepatol 29(2):191–197CrossRefPubMed
23.
Otedo AE, McLigeyo SO, Okoth FA, Kayima JK (2003) Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J 93(5):380–384PubMed
24.
Sakai N, Tatsuta M, Iishi H, Yano H, Osaka S, Aoki A (2001) Effectiveness of manual cleaning and disinfection of gastroendoscopes with 3% glutaraldehyde for decreasing the risk of transmission of Hepatitis C virus. Am J Gastroenterol 96(6):1803–1806CrossRefPubMed
25.
Center for Disease Control and Prevention (CDC) (2008) Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic—Nevada. MMWR 57(19):513–517
26.
Pekova L, Teocharov P, Sakarev A (2007) Clinical course and outcome of a nosocomial outbreak of hepatitis C in a urology ward. J Hosp Inf 67:86–91CrossRef
27.
Lédinghen V, Trimoulet P, Cazajous G, Bernard P-H, Schrive M-H, Foucher J, Faure M, Castéra L, Vergniol J, Amouretti M, Fleury H, Couzigou P (2003) Epidemiological and phylogenetic evidence for patient-to-patient hepatitis C virus transmission during sclerotherapy of varicose veins. J Med Virol 76:279–284CrossRef
28.
Froio N, Nicastri E, Comandini U, Cherubini C, Felicioni R, Solmone M, Di Giulio S, Petrosillo N (2003) Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis 42(3):546–550CrossRefPubMed
29.
Monsalve-Castillo F, Gomez-Gamboa L (2004) Hepatitis C virus. Iatrogenic and nosocomial transmition? Invest Clin 45(3):193–195PubMed
30.
Forns X, Martinèz-Bauer E, Feliu A, García-Retortillo M, Martin M, Gay E, Nevasa M, Sanchez-Tapias J, Bruguera M, Rodes J (2005) Nosocomial transmission of HCV in the liver unit of a tertiary care center. Hepatology 41(1):115–122CrossRefPubMed
31.
Beltrami EM, Williams IT, Shapiro CN, Chamberland ME (2000) Risk and management of blood-borne infection in health care workers. Clin Microbiol Rev 13(3):385–407CrossRefPubMed
32.
Yazdanpanah Y, De Carli G, Migueres B, Lot F, Campins M, Colombo C, Thomas T, Deuffic-Burban S, Prevot MH, Domart M, Tarantola A, Abiteboul D, Deny P, Pol S, Desenclos JC, Puro V, Bouvet E (2005) Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: European case-control study. Clin Infect Dis 41(1):1423–1430CrossRefPubMed
33.
Raggam RB, Rossmann AM, Salzer HJ, Stauber RE, Kessler HH (2009) Health care worker-to-patient transmission of hepatitis C virus in the health care setting: many questions and few answers. J Clin Virol 45(4):272–275CrossRefPubMed
34.
Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott E, Shaw-Stiffel T, Weston S, Theide H, Wald A, Rosen H (2007) Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Inf Dis 196:1474–1482CrossRef
35.
Murphy E, Bryzman S, Glynn S, Ameti D, Thomson R, Willian A, Nass C, Ownby H, Screiber G, Kong F, Neal F, Nemo G (2000) Risk factors for hepatitis C virus infection in United States blood donors. Hepatology 31(3):756–762CrossRefPubMed
36.
Raguin G, Rosenthal E, Cacoub P, Veyssier P, Piette JC, Micoud M (1998) Hepatitis C in France: a national survey in the Departments of Internal Medicine and Infectious Diseases. The GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases). Eur J Epidemiol 14(1):545–548CrossRefPubMed
37.
Ferrero MC, Dios PD, Scully C (2005) Transmission of hepatitis C virus by saliva? Oral Dis 11:230–235CrossRef
38.
Macías J, Palacios R, Claro E, Vargas J, Vergara S, Mira J, Merchante N, Corzo J, Pineda J (2008) High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack. Liver Inter 28(6):781–786CrossRef
39.
van den Berg C, van de Laar T, Kok A, Zuure F, Coutinho R, Prins M (2009) Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J Viral Hepat 16:568–577CrossRefPubMed
40.
Coppola N, Pisapia R, Marrocco C, Martini S, Vatiero LM, Messina V, Tonziello G, Sagnelli C, Filippini P, Piccinino F, Sagnelli E (2007) Anti-HCV IgG avidity index in acute hepatitis C. J Clin Virol 40(2):110–115CrossRefPubMed
41.
Sagnelli E, Coppola N, Marrocco C, Coviello G, Battaglia M, Messina V, Rossi G, Sagnelli C, Scolastico C, Filippini P (2005) Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. J Hepatol 42(5):646–651CrossRefPubMed
42.
Irving W, Salmon D, Boucher C, Hoepelman I (2008) Acute hepatitis C virus infection. EuroSurveill 13(21):1–4 (pii: 18879)
43.
Wasley A, Grytdal S, Gallagher K, Centres for Disease Control, Prevention (CDC) (2008) Surveillance for acute viral hepatitis—United States. MMWR Surveill Summ 57(2):1–24PubMed
44.
Vento S, Cainelli F, Longhi M (2002) Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue. Lancet Oncol 3(6):333–340CrossRefPubMed
45.
Ennishi D, Yokoyama M, Terui Y, Takeuchi K, Ikeda K, Tanimoto M, Hatake K (2008) Does rituximab really induce hepatitis C virus reactivation? J Clin Oncol 26(28):4695–4696CrossRefPubMed
46.
Cardell K, Widell A, Frydén A, Akerling B, Mansson A, Franzén S, Lymer U, Isaksson B (2008) Nosocomial hepatitis C in thoracic surgery unit; retrospective findings generating a prospective study. J Hosp Infect 68:322–328PubMed
47.
Molmenti E, Klintmalm G (2000) Hepatitis C recurrence after liver transplantation. Liver Transpl 6(4):413–414CrossRefPubMed
48.
Melon S, Galarraga M, Villar M, Laures A, Boga J, de Oña M, Gomez E (2005) Hepatitis C vírus reactivation in anti-hepatitic C virus-positive renal transplant recipients. Transpl Proc 37(5):2083–2085CrossRef
49.
Chen J, Chung J, Kao J, Chen D (2001) Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother. J Gastroenterol Hepatol 16(6):705–708CrossRefPubMed
50.
Humar A, Washburn K, Freeman R, Paya C, Mouas H, Alecock E, Razonable R (2007) An assessment of interactions between hepatitis C virus and Herpesvirus reactivation in liver transplant recipients using molecular surveillance. Liver Transpl 13:1422–1427CrossRefPubMed
Metadata
Title
Hidden hazards of HCV transmission
Author
Robério Amorim de Almeida Pondé
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 1/2011
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-010-0159-9

Other articles of this Issue 1/2011

Medical Microbiology and Immunology 1/2011 Go to the issue

Review

Oncomodulation by human cytomegalovirus: novel clinical findings open new roads

Original Investigation

Effect of inhibitors of arachidonic acid metabolism on prostaglandin E2 production by Candida albicans and Candida dubliniensis biofilms

Erratum

Erratum to: Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients

Original Investigation

Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients

Original Investigation

Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses

Rapid Communication

Characterization of the subcellular localization of herpes simplex virus type 1 proteins in living cells
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits